Search clinical trials for: dl-3-butylphthalide placebo

Total 1526 results

Fudan University

Recruiting

Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER) (Be-CLEVER)

Stroke | Post-stroke Cognitive Impairment (PSCI)

China
First Affiliated Hospital, Sun Yat-Sen University

Not yet recruiting

Efficacy of Butylphthalide on Symptomatic Atherosclerotic Stenosis in Middle Cerebral Artery (SICAS)

Ischemic Stroke, Acute | Intracranial Atherosclerosis

China
Beijing Tiantan Hospital

Completed

Efficacy and Safety of Butylphthalide for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis or Endovascular Treatment (BAST)

Acute Ischemic Stroke

China
Tianjin Medical University General Hospital

Unknown

The Efficacy of DL-NBP in Patients With Mild Subcortical Ischemic Vascular Dementia

Cerebral Small Vessel Diseases | Subcortical Vascular Dementia

China
yuanli Zhao
Peking University International Hospital

Not yet recruiting

NBP in Patients With Moyamoya Disease of High Risk for Ischemic Cerebrovascular Events (NICE-MMD)

Ischemic Stroke | Transient Ischemic Attack | Moyamoya Disease | Ischemic Cerebrovascular Accident | Ischemic Cerebral Infarction

China
First Affiliated Hospital Xi'an Jiaotong University

Completed

DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

Alzheimer's Disease

China
The Second Hospital of Hebei Medical University

Unknown

The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND (EBSCPVCIND)

Vascular Cognitive Impairment no Dementia

China
Shanghai 6th People's Hospital

Completed

Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke

Acute Cerebral Stroke Within 12 Hours for the First Time

China
Qianfoshan Hospital

Recruiting

For Patients With Ischemic Stroke, Clinically Study the Effectiveness and Safety of Butylphthalide.

Vascular Diseases | Stroke | Central Nervous System Diseases | Nervous System Diseases | Brain Ischemia | Cerebral Infarction | Brain Infarction

China
Yi Yang

Completed

Effectiveness of Butylphthalide on Dynamic Cerebral Autoregulation in Patients With Acute Ischemic Stroke. (EBCAS)

Acute Ischemic Stroke

China
Jinling Hospital, China
CSPC-NBP Pharmaceutical Co., Ltd.

Completed

Butylphthalide for Preventing Restenosis After Intracranial and Extracranial Artery Stenting (BPRIAS)

Restenosis

China
Capital Medical University
CSPC-NBP Pharmaceutical Co., Ltd.

Active, not recruiting

Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia

Vascular Dementia

China
Peking Union Medical College Hospital

Unknown

A Clinical Study on the Treatment of Cerebral Small Vascular Disease (MAP-CSVD)

Cerebral Small Vessel Diseases

China
Xin Huang

Completed

Using Real-world Evidence to Analyze the Clinical Effects and Adverse Events of Butylphthalide in Stroke Patients

Cardiovascular Diseases | Vascular Diseases | Stroke | Central Nervous System Diseases | Nervous System Diseases | Brain Ischemia | Cerebral Infarction | Brain Infarction

China
Tang Ziren

Not yet recruiting

Butylphthalide's Safety and Efficacy for Improving Neurological Function Prognosis in Patients With Cardiac Arrest (BNCA Trial)

Cardiac Arrest | Butylphthalide | Neuroprotective Drugs

China
The Second Hospital of Hebei Medical University

Unknown

Study of Collateral Circulation in Patients With Symptomatic Intracranial Anterior Circulation Occlusion

Cerebral Infarction | Collateral Circulation | Large-artery Occlusion

China
Peking Union Medical College Hospital

Unknown

The Effectiveness and Safety of Butylphthalide Soft Capsules in Secondary Prevention of Ischemic Stroke Trial (ESCAPE)

Stroke | Transient Ischemic Attack

China
Orphan Australia

Completed

VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease

Crohn's Disease

Australia
Daiichi Sankyo, Inc.

Completed

Effects on Colesevelam HC1 (WelChol®) on Insulin Sensitivity in Subjects With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Joslin Diabetes Center
University of Colorado, Denver; Washington University School of Medicine; Albert... and other collaborators

Completed

PERL Continuous Glucose Monitoring (CGM) Study

Diabetic Nephropathies

United States, Canada
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Recruiting

VSL#3® vs Placebo in the Treatment of Fatigue and Other Symptoms in Long Covid (DELong#3) (DELong#3)

Long COVID

Italy
University of Maryland, Baltimore
National Center for Complementary and Integrative Health (NCCIH)

Terminated

Safety of VSL#3 in Adult Asthmatics

Asthma

United States
Children's Hospital Los Angeles
Thrasher Research Fund; UCSF Benioff Children's Hospital Oakland

Completed

Nebulized Hypertonic Saline for Bronchiolitis

Bronchiolitis

United States
EMS

Withdrawn

Efficacy and Safety of Two Doses of Hipnos in the Treatment of Adults With Insomnia

Insomnia
Policlinico Hospital

Unknown

Impact of Probiotic Preparation VSL#3 on Infants Colics

Infant Colics

Italy
Policlinico Hospital

Completed

Influence of Probiotic VSL#3 Administration on Metabolic and Immunological Profile of the Milk of Breastfeeding Mothers

Allergy

Italy
Bambino Gesù Hospital and Research Institute

Completed

Effects of VSL#3 on Metabolic, Endocrine, Lipidomic and Inflammatory Parameters of Pediatric Patients With BMI>90° (VAIIO)

Obesity

Italy
MGB Biopharma Limited
Hammersmith Medicines Research; Innovate UK; Cambridge Regulatory Services; Phases... and other collaborators

Completed

Safety, Blood Levels and Effects of MGB-BP-3

Healthy
University of Michigan

Completed

Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC)

Hirschsprung Disease

United States
University of Dublin, Trinity College
Actial Farmaceutica S.r.l.

Unknown

Investigating the Effect of Dietary Supplement VSL#3 on Cognition and Mood in Healthy Older Adults

Alteration of Cognitive Function | Disturbance in Affect (Finding)

Ireland
Catholic University of the Sacred Heart

Unknown

VSL#3 Versus Placebo in Increasing the Pathological Major Response Rate in Patients With Rectal Cancer

Rectal Cancer

Italy
Assistance Publique - Hôpitaux de Paris

Active, not recruiting

Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA) (PERMAJI)

Juvenile Idiopathic Arthritis

France
Clinical Nutrition Research Center, Illinois Institute...

Completed

Absorption and Metabolic Profiles of a Sugar-based Beverage (SR)

Healthy | Overweight

United States
Elena Pita Calandre
Ferring Pharmaceuticals; Actial Farmaceutica S.r.l.

Completed

Probiotic VSL#3 for the Treatment of Gastrointestinal Symptoms Associated to Fibromyalgia

Fibromyalgia | Gastrointestinal Disease

Spain
University of Aarhus

Completed

How Orally Consumed 3-hydroxybuturate Alters Metabolism

Acute Ketosis

Denmark
Boehringer Ingelheim

Completed

Pharmacokinetics and Pharmacodynamics of BIWH 3 in Healthy Duffy Positive vs. Duffy Negative Male Volunteers

Healthy
Boehringer Ingelheim

Terminated

Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia (COINART-1)

Peripheral Arterial Disease
Children's Mercy Hospital Kansas City
VSL Pharmaceuticals

Completed

Effect of VSL#3 on Intestinal Permeability in Pediatric Crohn's Disease

Crohn's Disease

United States
Dayton Children's Hospital
National Institutes of Health (NIH)

Terminated

The Use of VSL#3 in Irritable Bowel Syndrome in Children (VSL#3)

Irritable Bowel Syndrome

United States
University of Utah
United States Department of Defense

Terminated

Probiotic (VSL #3) for Gulf War Illness

Gulf War Illness

United States
Hadassah Medical Organization

Unknown

VSL#3 Treatment in Children With Crohn's Disease

Crohn's Disease

Israel
MedImmune LLC

Withdrawn

Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat Influenza

Influenza
Bayer

Terminated

Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

Breast Neoplasms

Spain, Canada, United States, Finland, Austria, Singapore, Czechia, Israel, Korea, Republic of, Netherlands, Taiwan, United Kingdom, Poland, Germany, Hong Kong, Denmark, Switzerland, Ireland, France, Norway
University College, London

Active, not recruiting

Semaglutide 2.4 mg in Patients With Poor Weight-loss (BARI-STEP)

Obesity | Diabetes | Metabolic Syndrome

United Kingdom
AstraZeneca

Active, not recruiting

Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

COVID-19, SARS-CoV-2

Japan
Bial - Portela C S.A.

Completed

Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic and Pharmacodynamic Profile of BIA 3-202

Parkinson's Disease

United Kingdom
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Breast Neoplasms | Arthralgia

United States
University Hospital, Lille

Terminated

Nasal Mucin Oral Supplementation Treatment Respiratory Inflammation Using PUFA in Cystic Fibrosis (CF) Patients (NOSTRIL)

Cystic Fibrosis | Dietary Modification

France
Merck Sharp & Dohme LLC

Active, not recruiting

Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated With Experimental Influenza Virus (MK-4482-019)

Influenza Infection

United Kingdom
Ashok Tuteja
United States Department of Defense

Unknown

Probiotic (Visbiome) for Gulf War Illness

Gulf War Illness

United States

Search clinical trials for: dl-3-butylphthalide placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations